M&A Has Been Down, But EY Argues Conditions Are Right For An Uptick In 2023

 
• By Joseph Haas
  
M&A
EY predicts an increase in M&A this year despite stricter due diligence • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business